What is XCellR8?
XCellR8 stands as the UK's foremost animal-free testing laboratory, distinguished by its innovative approach to safety testing that eschews animal or animal product utilization. With nearly two decades of operational experience, the company offers GLP-accredited testing methods, widely accepted by global regulatory bodies. XCellR8 serves a broad spectrum of clients, from emerging startups to established industry leaders such as Lush and Unilever, providing essential services including safety and claims testing, alongside custom testing solutions. Their core mission is to accelerate the global shift towards 100% animal-free testing protocols, thereby ensuring the delivery of reliable scientific data and supporting vegan product claims.
How much funding has XCellR8 raised?
XCellR8 has raised a total of $140K across 1 funding round:
Unspecified
$140K
Unspecified (2021): $140K with participation from Unilever and AstraZeneca
Key Investors in XCellR8
Unilever
Unilever is a multinational consumer goods company with a broad portfolio, likely investing in XCellR8 to support its sustainability initiatives and ethical product development, particularly in the beauty and personal care sectors.
AstraZeneca
AstraZeneca is a global biopharmaceutical company focused on prescription medicines. Their investment may indicate an interest in novel non-animal testing methodologies for drug safety and efficacy assessment, aligning with broader industry trends towards alternative testing strategies.
What's next for XCellR8?
The recent strategic investment signifies a pivotal moment for XCellR8, positioning the company for accelerated growth and expanded market penetration. This backing is expected to fuel further development of their proprietary testing technologies and enhance their capacity to meet the escalating global demand for ethical and regulatory-compliant product assessment. XCellR8's commitment to innovation and its established reputation for delivering high-quality, animal-free data are key drivers for its continued success in the evolving landscape of product safety and regulatory science.
See full XCellR8 company page
